The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...
Female sex, antidepressant use, and type of health insurance significantly influence semaglutide initiation. (HealthDay News) — Sociodemographic, health care, and clinical factors are associated with ...
Adults with obesity receiving once-weekly semaglutide 7.2 mg lost a higher proportion of their body weight at 72 weeks than ...
Novo Nordisk stock falls as Medicare selects its marketed semaglutide medicines catering to T2D and obesity for price ...
Significant associations for semaglutide initiation included being female, using certain medication classes including antidepressants, and being covered by a point-of-service plan. (HealthDay News ...
INSIDER on MSN8d
A woman regained weight after she stopped taking semaglutide. Now she works 2 jobs to afford it.A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...
News Medical on MSN7d
Why do people with obesity, but without diabetes, start taking semaglutide?Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...
Semaglutide, a medication originally designed to treat type 2 diabetes, has recently gained significant attention as a weight ...
Addressing these inequities is crucial to reducing the obesity burden. The current study sought to explore the factors that control semaglutide initiation among obese adults without diabetes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback